MCO
78
4
PEP
32
3
AIG
62
2
MET
76
7
WYNN
50
6
VFC
67
8
THC
65
3
SRE
54
-10
ED
45
-4
WFC
83
6
DHR
52
7
HPQ
73
10
PNW
59
-3
INTC
35
6
NAVI
50
3
MLM
56
3
UNP
53
11
UHS
74
8
HRB
63
2
APH
83
3
MCO
78
4
PEP
32
3
AIG
62
2
MET
76
7
WYNN
50
6
VFC
67
8
THC
65
3
SRE
54
-10
ED
45
-4
WFC
83
6
DHR
52
7
HPQ
73
10
PNW
59
-3
INTC
35
6
NAVI
50
3
MLM
56
3
UNP
53
11
UHS
74
8
HRB
63
2
APH
83
3
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
41

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
$41.50
Seasonality Move:
12.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed investing in Uber? Don't Miss Mode.

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 22.8% based on the past 15 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $43.10. The Score for BIB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 22.8% based on the past 15 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
41
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
33.78

Prediction Charts

Market Cap:
0
Price in USD:
43.10
Volume:
35.6K
Beta:
1.83

Technical Analysis

SMA50:
47.13
SMA100:
50.40
SMA200:
56.68
52-Wk Change:
-20.87%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 43.10 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-23 44.92 44.35 45.70 44.30
Apr-24 44.01 46.00 46.00 44.01
Apr-25 44.69 44.61 45.40 44.43
Apr-28 44.89 45.87 46.16 44.89
Apr-29 44.77 46.11 46.39 44.43
Apr-30 46.58 47.46 47.46 45.70
May-1 46.75 46.31 47.14 46.22
May-2 47.87 47.58 47.96 47.48
May-5 47.54 46.91 47.54 46.74
May-6 45.32 41.26 45.63 41.21
May-7 41.33 41.56 41.75 40.81
May-8 40.63 41.24 41.88 39.47
May-9 41.00 39.63 42.23 39.63
May-12 40.09 43.10 43.42 40.09

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.